nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—CYP3A5—Beclomethasone—psoriasis	0.0806	0.113	CbGbCtD
Trazodone—CYP2D6—Hydroxyurea—psoriasis	0.0374	0.0527	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0343	0.0483	CbGbCtD
Trazodone—CYP3A7—Hydrocortisone—psoriasis	0.0343	0.0483	CbGbCtD
Trazodone—CYP3A7—Cyclosporine—psoriasis	0.0324	0.0456	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0324	0.0456	CbGbCtD
Trazodone—CYP3A5—Mycophenolate mofetil—psoriasis	0.0321	0.0451	CbGbCtD
Trazodone—CYP3A4—Calcitriol—psoriasis	0.028	0.0394	CbGbCtD
Trazodone—CYP3A5—Hydrocortisone—psoriasis	0.0257	0.0362	CbGbCtD
Trazodone—CYP3A5—Cyclosporine—psoriasis	0.0243	0.0342	CbGbCtD
Trazodone—CYP2D6—Cholecalciferol—psoriasis	0.0227	0.0319	CbGbCtD
Trazodone—CYP3A4—Methoxsalen—psoriasis	0.0218	0.0307	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.0213	0.03	CbGbCtD
Trazodone—CYP3A7—Dexamethasone—psoriasis	0.0213	0.03	CbGbCtD
Trazodone—ABCB1—Mycophenolate mofetil—psoriasis	0.0209	0.0294	CbGbCtD
Trazodone—ABCB1—Betamethasone—psoriasis	0.0179	0.0252	CbGbCtD
Trazodone—ABCB1—Prednisolone—psoriasis	0.0177	0.0249	CbGbCtD
Trazodone—ABCB1—Hydrocortisone—psoriasis	0.0168	0.0236	CbGbCtD
Trazodone—ABCB1—Prednisone—psoriasis	0.0167	0.0235	CbGbCtD
Trazodone—CYP3A5—Dexamethasone—psoriasis	0.016	0.0225	CbGbCtD
Trazodone—ABCB1—Cyclosporine—psoriasis	0.0158	0.0223	CbGbCtD
Trazodone—CYP2D6—Cyclosporine—psoriasis	0.0149	0.021	CbGbCtD
Trazodone—CYP3A4—Cholecalciferol—psoriasis	0.0144	0.0203	CbGbCtD
Trazodone—CYP3A4—Mycophenolate mofetil—psoriasis	0.0125	0.0176	CbGbCtD
Trazodone—CYP3A4—Triamcinolone—psoriasis	0.0125	0.0176	CbGbCtD
Trazodone—CYP3A4—Betamethasone—psoriasis	0.0107	0.0151	CbGbCtD
Trazodone—CYP3A4—Prednisolone—psoriasis	0.0106	0.0149	CbGbCtD
Trazodone—ABCB1—Dexamethasone—psoriasis	0.0104	0.0147	CbGbCtD
Trazodone—CYP3A4—Hydrocortisone—psoriasis	0.01	0.0141	CbGbCtD
Trazodone—CYP3A4—Prednisone—psoriasis	0.01	0.0141	CbGbCtD
Trazodone—CYP2D6—Dexamethasone—psoriasis	0.00982	0.0138	CbGbCtD
Trazodone—CYP3A4—Cyclosporine—psoriasis	0.00948	0.0133	CbGbCtD
Trazodone—ABCB1—Methotrexate—psoriasis	0.00837	0.0118	CbGbCtD
Trazodone—CYP3A4—Dexamethasone—psoriasis	0.00624	0.00879	CbGbCtD
Trazodone—Dry mouth—Triamcinolone—psoriasis	0.00015	0.000548	CcSEcCtD
Trazodone—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000149	0.000544	CcSEcCtD
Trazodone—Anorexia—Hydrocortisone—psoriasis	0.000149	0.000544	CcSEcCtD
Trazodone—Diarrhoea—Mycophenolic acid—psoriasis	0.000148	0.000543	CcSEcCtD
Trazodone—Malaise—Dexamethasone—psoriasis	0.000147	0.000539	CcSEcCtD
Trazodone—Malaise—Betamethasone—psoriasis	0.000147	0.000539	CcSEcCtD
Trazodone—Oedema—Triamcinolone—psoriasis	0.000147	0.000537	CcSEcCtD
Trazodone—Vertigo—Dexamethasone—psoriasis	0.000147	0.000537	CcSEcCtD
Trazodone—Vertigo—Betamethasone—psoriasis	0.000147	0.000537	CcSEcCtD
Trazodone—Syncope—Dexamethasone—psoriasis	0.000146	0.000536	CcSEcCtD
Trazodone—Syncope—Betamethasone—psoriasis	0.000146	0.000536	CcSEcCtD
Trazodone—Pain—Mycophenolate mofetil—psoriasis	0.000146	0.000535	CcSEcCtD
Trazodone—Constipation—Mycophenolate mofetil—psoriasis	0.000146	0.000535	CcSEcCtD
Trazodone—Arrhythmia—Prednisone—psoriasis	0.000146	0.000534	CcSEcCtD
Trazodone—Sweating—Methotrexate—psoriasis	0.000146	0.000533	CcSEcCtD
Trazodone—Hypotension—Hydrocortisone—psoriasis	0.000146	0.000533	CcSEcCtD
Trazodone—Haematuria—Methotrexate—psoriasis	0.000145	0.00053	CcSEcCtD
Trazodone—Feeling abnormal—Cyclosporine—psoriasis	0.000145	0.000529	CcSEcCtD
Trazodone—Shock—Triamcinolone—psoriasis	0.000144	0.000528	CcSEcCtD
Trazodone—Insomnia—Prednisolone—psoriasis	0.000144	0.000528	CcSEcCtD
Trazodone—Alopecia—Prednisone—psoriasis	0.000144	0.000528	CcSEcCtD
Trazodone—Gastrointestinal pain—Cyclosporine—psoriasis	0.000143	0.000525	CcSEcCtD
Trazodone—Loss of consciousness—Dexamethasone—psoriasis	0.000143	0.000525	CcSEcCtD
Trazodone—Loss of consciousness—Betamethasone—psoriasis	0.000143	0.000525	CcSEcCtD
Trazodone—Dizziness—Mycophenolic acid—psoriasis	0.000143	0.000525	CcSEcCtD
Trazodone—Paraesthesia—Prednisolone—psoriasis	0.000143	0.000524	CcSEcCtD
Trazodone—Tachycardia—Triamcinolone—psoriasis	0.000143	0.000524	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000142	0.00052	CcSEcCtD
Trazodone—Hyperhidrosis—Triamcinolone—psoriasis	0.000142	0.000519	CcSEcCtD
Trazodone—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000141	0.000516	CcSEcCtD
Trazodone—Insomnia—Hydrocortisone—psoriasis	0.000141	0.000516	CcSEcCtD
Trazodone—Hypertension—Dexamethasone—psoriasis	0.000141	0.000516	CcSEcCtD
Trazodone—Hypertension—Betamethasone—psoriasis	0.000141	0.000516	CcSEcCtD
Trazodone—Paraesthesia—Hydrocortisone—psoriasis	0.00014	0.000512	CcSEcCtD
Trazodone—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.00014	0.000512	CcSEcCtD
Trazodone—Urticaria—Cyclosporine—psoriasis	0.000139	0.00051	CcSEcCtD
Trazodone—Myalgia—Betamethasone—psoriasis	0.000139	0.000508	CcSEcCtD
Trazodone—Myalgia—Dexamethasone—psoriasis	0.000139	0.000508	CcSEcCtD
Trazodone—Abdominal pain—Cyclosporine—psoriasis	0.000139	0.000507	CcSEcCtD
Trazodone—Body temperature increased—Cyclosporine—psoriasis	0.000139	0.000507	CcSEcCtD
Trazodone—Anxiety—Dexamethasone—psoriasis	0.000138	0.000507	CcSEcCtD
Trazodone—Anxiety—Betamethasone—psoriasis	0.000138	0.000507	CcSEcCtD
Trazodone—Vomiting—Mycophenolic acid—psoriasis	0.000138	0.000504	CcSEcCtD
Trazodone—Discomfort—Dexamethasone—psoriasis	0.000137	0.000502	CcSEcCtD
Trazodone—Discomfort—Betamethasone—psoriasis	0.000137	0.000502	CcSEcCtD
Trazodone—Rash—Mycophenolic acid—psoriasis	0.000137	0.0005	CcSEcCtD
Trazodone—Dermatitis—Mycophenolic acid—psoriasis	0.000137	0.0005	CcSEcCtD
Trazodone—Pain—Prednisolone—psoriasis	0.000136	0.000499	CcSEcCtD
Trazodone—Urticaria—Mycophenolate mofetil—psoriasis	0.000136	0.000497	CcSEcCtD
Trazodone—Headache—Mycophenolic acid—psoriasis	0.000136	0.000497	CcSEcCtD
Trazodone—Decreased appetite—Hydrocortisone—psoriasis	0.000135	0.000496	CcSEcCtD
Trazodone—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000135	0.000495	CcSEcCtD
Trazodone—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000135	0.000495	CcSEcCtD
Trazodone—Fatigue—Hydrocortisone—psoriasis	0.000134	0.000492	CcSEcCtD
Trazodone—Vision blurred—Prednisone—psoriasis	0.000134	0.00049	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000134	0.000489	CcSEcCtD
Trazodone—Pain—Hydrocortisone—psoriasis	0.000133	0.000488	CcSEcCtD
Trazodone—Oedema—Betamethasone—psoriasis	0.000133	0.000487	CcSEcCtD
Trazodone—Oedema—Dexamethasone—psoriasis	0.000133	0.000487	CcSEcCtD
Trazodone—Insomnia—Triamcinolone—psoriasis	0.000133	0.000486	CcSEcCtD
Trazodone—Ill-defined disorder—Prednisone—psoriasis	0.000132	0.000483	CcSEcCtD
Trazodone—Paraesthesia—Triamcinolone—psoriasis	0.000132	0.000482	CcSEcCtD
Trazodone—Feeling abnormal—Prednisolone—psoriasis	0.000132	0.000481	CcSEcCtD
Trazodone—Visual impairment—Methotrexate—psoriasis	0.000131	0.000481	CcSEcCtD
Trazodone—Anaemia—Prednisone—psoriasis	0.000131	0.000481	CcSEcCtD
Trazodone—Shock—Dexamethasone—psoriasis	0.000131	0.000479	CcSEcCtD
Trazodone—Shock—Betamethasone—psoriasis	0.000131	0.000479	CcSEcCtD
Trazodone—Dyspnoea—Triamcinolone—psoriasis	0.000131	0.000479	CcSEcCtD
Trazodone—Agitation—Prednisone—psoriasis	0.000131	0.000478	CcSEcCtD
Trazodone—Tachycardia—Dexamethasone—psoriasis	0.00013	0.000476	CcSEcCtD
Trazodone—Tachycardia—Betamethasone—psoriasis	0.00013	0.000476	CcSEcCtD
Trazodone—Hypersensitivity—Cyclosporine—psoriasis	0.000129	0.000473	CcSEcCtD
Trazodone—Nausea—Mycophenolic acid—psoriasis	0.000129	0.000471	CcSEcCtD
Trazodone—Hyperhidrosis—Dexamethasone—psoriasis	0.000129	0.000471	CcSEcCtD
Trazodone—Hyperhidrosis—Betamethasone—psoriasis	0.000129	0.000471	CcSEcCtD
Trazodone—Feeling abnormal—Hydrocortisone—psoriasis	0.000128	0.00047	CcSEcCtD
Trazodone—Malaise—Prednisone—psoriasis	0.000128	0.000469	CcSEcCtD
Trazodone—Vertigo—Prednisone—psoriasis	0.000128	0.000467	CcSEcCtD
Trazodone—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000127	0.000466	CcSEcCtD
Trazodone—Syncope—Prednisone—psoriasis	0.000127	0.000466	CcSEcCtD
Trazodone—Tinnitus—Methotrexate—psoriasis	0.000127	0.000466	CcSEcCtD
Trazodone—Anorexia—Dexamethasone—psoriasis	0.000127	0.000465	CcSEcCtD
Trazodone—Anorexia—Betamethasone—psoriasis	0.000127	0.000465	CcSEcCtD
Trazodone—Urticaria—Prednisolone—psoriasis	0.000127	0.000464	CcSEcCtD
Trazodone—Fatigue—Triamcinolone—psoriasis	0.000127	0.000463	CcSEcCtD
Trazodone—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000126	0.000461	CcSEcCtD
Trazodone—Asthenia—Cyclosporine—psoriasis	0.000126	0.000461	CcSEcCtD
Trazodone—Pain—Triamcinolone—psoriasis	0.000126	0.000459	CcSEcCtD
Trazodone—Loss of consciousness—Prednisone—psoriasis	0.000125	0.000457	CcSEcCtD
Trazodone—Hypotension—Betamethasone—psoriasis	0.000124	0.000455	CcSEcCtD
Trazodone—Hypotension—Dexamethasone—psoriasis	0.000124	0.000455	CcSEcCtD
Trazodone—Pruritus—Cyclosporine—psoriasis	0.000124	0.000454	CcSEcCtD
Trazodone—Urticaria—Hydrocortisone—psoriasis	0.000124	0.000453	CcSEcCtD
Trazodone—Body temperature increased—Hydrocortisone—psoriasis	0.000123	0.000451	CcSEcCtD
Trazodone—Abdominal pain—Hydrocortisone—psoriasis	0.000123	0.000451	CcSEcCtD
Trazodone—Asthenia—Mycophenolate mofetil—psoriasis	0.000123	0.000449	CcSEcCtD
Trazodone—Hypertension—Prednisone—psoriasis	0.000123	0.000449	CcSEcCtD
Trazodone—Chills—Methotrexate—psoriasis	0.000122	0.000448	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000121	0.000444	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000121	0.000444	CcSEcCtD
Trazodone—Pruritus—Mycophenolate mofetil—psoriasis	0.000121	0.000443	CcSEcCtD
Trazodone—Arthralgia—Prednisone—psoriasis	0.000121	0.000443	CcSEcCtD
Trazodone—Myalgia—Prednisone—psoriasis	0.000121	0.000443	CcSEcCtD
Trazodone—Feeling abnormal—Triamcinolone—psoriasis	0.000121	0.000443	CcSEcCtD
Trazodone—Anxiety—Prednisone—psoriasis	0.000121	0.000441	CcSEcCtD
Trazodone—Alopecia—Methotrexate—psoriasis	0.000121	0.000441	CcSEcCtD
Trazodone—Insomnia—Betamethasone—psoriasis	0.00012	0.000441	CcSEcCtD
Trazodone—Insomnia—Dexamethasone—psoriasis	0.00012	0.000441	CcSEcCtD
Trazodone—Diarrhoea—Cyclosporine—psoriasis	0.00012	0.000439	CcSEcCtD
Trazodone—Paraesthesia—Betamethasone—psoriasis	0.00012	0.000438	CcSEcCtD
Trazodone—Paraesthesia—Dexamethasone—psoriasis	0.00012	0.000438	CcSEcCtD
Trazodone—Discomfort—Prednisone—psoriasis	0.00012	0.000437	CcSEcCtD
Trazodone—Hypersensitivity—Prednisolone—psoriasis	0.000118	0.00043	CcSEcCtD
Trazodone—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000117	0.000428	CcSEcCtD
Trazodone—Urticaria—Triamcinolone—psoriasis	0.000117	0.000427	CcSEcCtD
Trazodone—Dysgeusia—Methotrexate—psoriasis	0.000116	0.000426	CcSEcCtD
Trazodone—Body temperature increased—Triamcinolone—psoriasis	0.000116	0.000425	CcSEcCtD
Trazodone—Dizziness—Cyclosporine—psoriasis	0.000116	0.000424	CcSEcCtD
Trazodone—Oedema—Prednisone—psoriasis	0.000116	0.000424	CcSEcCtD
Trazodone—Decreased appetite—Betamethasone—psoriasis	0.000116	0.000424	CcSEcCtD
Trazodone—Decreased appetite—Dexamethasone—psoriasis	0.000116	0.000424	CcSEcCtD
Trazodone—Back pain—Methotrexate—psoriasis	0.000115	0.00042	CcSEcCtD
Trazodone—Hypersensitivity—Hydrocortisone—psoriasis	0.000115	0.00042	CcSEcCtD
Trazodone—Fatigue—Betamethasone—psoriasis	0.000115	0.00042	CcSEcCtD
Trazodone—Fatigue—Dexamethasone—psoriasis	0.000115	0.00042	CcSEcCtD
Trazodone—Shock—Prednisone—psoriasis	0.000114	0.000418	CcSEcCtD
Trazodone—Pain—Dexamethasone—psoriasis	0.000114	0.000417	CcSEcCtD
Trazodone—Pain—Betamethasone—psoriasis	0.000114	0.000417	CcSEcCtD
Trazodone—Tachycardia—Prednisone—psoriasis	0.000113	0.000414	CcSEcCtD
Trazodone—Dizziness—Mycophenolate mofetil—psoriasis	0.000113	0.000414	CcSEcCtD
Trazodone—Hyperhidrosis—Prednisone—psoriasis	0.000112	0.00041	CcSEcCtD
Trazodone—Vision blurred—Methotrexate—psoriasis	0.000112	0.00041	CcSEcCtD
Trazodone—Asthenia—Hydrocortisone—psoriasis	0.000112	0.000409	CcSEcCtD
Trazodone—Vomiting—Cyclosporine—psoriasis	0.000112	0.000408	CcSEcCtD
Trazodone—Rash—Cyclosporine—psoriasis	0.000111	0.000405	CcSEcCtD
Trazodone—Anorexia—Prednisone—psoriasis	0.000111	0.000405	CcSEcCtD
Trazodone—Dermatitis—Cyclosporine—psoriasis	0.00011	0.000404	CcSEcCtD
Trazodone—Pruritus—Hydrocortisone—psoriasis	0.00011	0.000404	CcSEcCtD
Trazodone—Ill-defined disorder—Methotrexate—psoriasis	0.00011	0.000403	CcSEcCtD
Trazodone—Headache—Cyclosporine—psoriasis	0.00011	0.000402	CcSEcCtD
Trazodone—Anaemia—Methotrexate—psoriasis	0.00011	0.000402	CcSEcCtD
Trazodone—Feeling abnormal—Dexamethasone—psoriasis	0.00011	0.000402	CcSEcCtD
Trazodone—Feeling abnormal—Betamethasone—psoriasis	0.00011	0.000402	CcSEcCtD
Trazodone—Gastrointestinal pain—Dexamethasone—psoriasis	0.000109	0.000399	CcSEcCtD
Trazodone—Gastrointestinal pain—Betamethasone—psoriasis	0.000109	0.000399	CcSEcCtD
Trazodone—Vomiting—Mycophenolate mofetil—psoriasis	0.000109	0.000398	CcSEcCtD
Trazodone—Hypersensitivity—Triamcinolone—psoriasis	0.000108	0.000396	CcSEcCtD
Trazodone—Rash—Mycophenolate mofetil—psoriasis	0.000108	0.000395	CcSEcCtD
Trazodone—Dermatitis—Mycophenolate mofetil—psoriasis	0.000108	0.000394	CcSEcCtD
Trazodone—Headache—Mycophenolate mofetil—psoriasis	0.000107	0.000392	CcSEcCtD
Trazodone—Malaise—Methotrexate—psoriasis	0.000107	0.000392	CcSEcCtD
Trazodone—Vertigo—Methotrexate—psoriasis	0.000107	0.00039	CcSEcCtD
Trazodone—Diarrhoea—Hydrocortisone—psoriasis	0.000107	0.00039	CcSEcCtD
Trazodone—Urticaria—Dexamethasone—psoriasis	0.000106	0.000387	CcSEcCtD
Trazodone—Urticaria—Betamethasone—psoriasis	0.000106	0.000387	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Prednisone—psoriasis	0.000106	0.000387	CcSEcCtD
Trazodone—Dizziness—Prednisolone—psoriasis	0.000106	0.000386	CcSEcCtD
Trazodone—Asthenia—Triamcinolone—psoriasis	0.000105	0.000385	CcSEcCtD
Trazodone—Abdominal pain—Betamethasone—psoriasis	0.000105	0.000385	CcSEcCtD
Trazodone—Body temperature increased—Dexamethasone—psoriasis	0.000105	0.000385	CcSEcCtD
Trazodone—Body temperature increased—Betamethasone—psoriasis	0.000105	0.000385	CcSEcCtD
Trazodone—Abdominal pain—Dexamethasone—psoriasis	0.000105	0.000385	CcSEcCtD
Trazodone—Insomnia—Prednisone—psoriasis	0.000105	0.000384	CcSEcCtD
Trazodone—Nausea—Cyclosporine—psoriasis	0.000104	0.000381	CcSEcCtD
Trazodone—Paraesthesia—Prednisone—psoriasis	0.000104	0.000381	CcSEcCtD
Trazodone—Pruritus—Triamcinolone—psoriasis	0.000104	0.00038	CcSEcCtD
Trazodone—Dizziness—Hydrocortisone—psoriasis	0.000103	0.000377	CcSEcCtD
Trazodone—Nausea—Mycophenolate mofetil—psoriasis	0.000102	0.000372	CcSEcCtD
Trazodone—Arthralgia—Methotrexate—psoriasis	0.000101	0.00037	CcSEcCtD
Trazodone—Chest pain—Methotrexate—psoriasis	0.000101	0.00037	CcSEcCtD
Trazodone—Myalgia—Methotrexate—psoriasis	0.000101	0.00037	CcSEcCtD
Trazodone—Decreased appetite—Prednisone—psoriasis	0.000101	0.000369	CcSEcCtD
Trazodone—Rash—Prednisolone—psoriasis	0.000101	0.000368	CcSEcCtD
Trazodone—Dermatitis—Prednisolone—psoriasis	0.000101	0.000368	CcSEcCtD
Trazodone—Fatigue—Prednisone—psoriasis	0.0001	0.000366	CcSEcCtD
Trazodone—Headache—Prednisolone—psoriasis	0.0001	0.000366	CcSEcCtD
Trazodone—Discomfort—Methotrexate—psoriasis	9.99e-05	0.000366	CcSEcCtD
Trazodone—Constipation—Prednisone—psoriasis	9.92e-05	0.000363	CcSEcCtD
Trazodone—Vomiting—Hydrocortisone—psoriasis	9.91e-05	0.000363	CcSEcCtD
Trazodone—Rash—Hydrocortisone—psoriasis	9.83e-05	0.00036	CcSEcCtD
Trazodone—Dermatitis—Hydrocortisone—psoriasis	9.82e-05	0.000359	CcSEcCtD
Trazodone—Confusional state—Methotrexate—psoriasis	9.77e-05	0.000358	CcSEcCtD
Trazodone—Headache—Hydrocortisone—psoriasis	9.76e-05	0.000357	CcSEcCtD
Trazodone—Dizziness—Triamcinolone—psoriasis	9.71e-05	0.000355	CcSEcCtD
Trazodone—Feeling abnormal—Prednisone—psoriasis	9.56e-05	0.00035	CcSEcCtD
Trazodone—Asthenia—Betamethasone—psoriasis	9.55e-05	0.00035	CcSEcCtD
Trazodone—Asthenia—Dexamethasone—psoriasis	9.55e-05	0.00035	CcSEcCtD
Trazodone—Gastrointestinal pain—Prednisone—psoriasis	9.48e-05	0.000347	CcSEcCtD
Trazodone—Nausea—Prednisolone—psoriasis	9.48e-05	0.000347	CcSEcCtD
Trazodone—Pruritus—Dexamethasone—psoriasis	9.42e-05	0.000345	CcSEcCtD
Trazodone—Pruritus—Betamethasone—psoriasis	9.42e-05	0.000345	CcSEcCtD
Trazodone—Hyperhidrosis—Methotrexate—psoriasis	9.37e-05	0.000343	CcSEcCtD
Trazodone—Vomiting—Triamcinolone—psoriasis	9.33e-05	0.000342	CcSEcCtD
Trazodone—Nausea—Hydrocortisone—psoriasis	9.26e-05	0.000339	CcSEcCtD
Trazodone—Rash—Triamcinolone—psoriasis	9.25e-05	0.000339	CcSEcCtD
Trazodone—Dermatitis—Triamcinolone—psoriasis	9.25e-05	0.000338	CcSEcCtD
Trazodone—Anorexia—Methotrexate—psoriasis	9.24e-05	0.000338	CcSEcCtD
Trazodone—Urticaria—Prednisone—psoriasis	9.21e-05	0.000337	CcSEcCtD
Trazodone—Headache—Triamcinolone—psoriasis	9.19e-05	0.000336	CcSEcCtD
Trazodone—Abdominal pain—Prednisone—psoriasis	9.17e-05	0.000336	CcSEcCtD
Trazodone—Body temperature increased—Prednisone—psoriasis	9.17e-05	0.000336	CcSEcCtD
Trazodone—Diarrhoea—Betamethasone—psoriasis	9.11e-05	0.000333	CcSEcCtD
Trazodone—Diarrhoea—Dexamethasone—psoriasis	9.11e-05	0.000333	CcSEcCtD
Trazodone—Hypotension—Methotrexate—psoriasis	9.06e-05	0.000331	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Methotrexate—psoriasis	8.83e-05	0.000323	CcSEcCtD
Trazodone—Dizziness—Dexamethasone—psoriasis	8.81e-05	0.000322	CcSEcCtD
Trazodone—Dizziness—Betamethasone—psoriasis	8.81e-05	0.000322	CcSEcCtD
Trazodone—Insomnia—Methotrexate—psoriasis	8.77e-05	0.000321	CcSEcCtD
Trazodone—Nausea—Triamcinolone—psoriasis	8.72e-05	0.000319	CcSEcCtD
Trazodone—Paraesthesia—Methotrexate—psoriasis	8.7e-05	0.000319	CcSEcCtD
Trazodone—Dyspnoea—Methotrexate—psoriasis	8.64e-05	0.000316	CcSEcCtD
Trazodone—Somnolence—Methotrexate—psoriasis	8.62e-05	0.000315	CcSEcCtD
Trazodone—Hypersensitivity—Prednisone—psoriasis	8.54e-05	0.000313	CcSEcCtD
Trazodone—Vomiting—Dexamethasone—psoriasis	8.47e-05	0.00031	CcSEcCtD
Trazodone—Vomiting—Betamethasone—psoriasis	8.47e-05	0.00031	CcSEcCtD
Trazodone—Decreased appetite—Methotrexate—psoriasis	8.43e-05	0.000308	CcSEcCtD
Trazodone—Rash—Dexamethasone—psoriasis	8.4e-05	0.000307	CcSEcCtD
Trazodone—Rash—Betamethasone—psoriasis	8.4e-05	0.000307	CcSEcCtD
Trazodone—Dermatitis—Dexamethasone—psoriasis	8.39e-05	0.000307	CcSEcCtD
Trazodone—Dermatitis—Betamethasone—psoriasis	8.39e-05	0.000307	CcSEcCtD
Trazodone—Fatigue—Methotrexate—psoriasis	8.36e-05	0.000306	CcSEcCtD
Trazodone—Headache—Dexamethasone—psoriasis	8.34e-05	0.000305	CcSEcCtD
Trazodone—Headache—Betamethasone—psoriasis	8.34e-05	0.000305	CcSEcCtD
Trazodone—Asthenia—Prednisone—psoriasis	8.32e-05	0.000305	CcSEcCtD
Trazodone—Pain—Methotrexate—psoriasis	8.29e-05	0.000303	CcSEcCtD
Trazodone—Pruritus—Prednisone—psoriasis	8.2e-05	0.0003	CcSEcCtD
Trazodone—Feeling abnormal—Methotrexate—psoriasis	7.99e-05	0.000292	CcSEcCtD
Trazodone—Diarrhoea—Prednisone—psoriasis	7.93e-05	0.00029	CcSEcCtD
Trazodone—Gastrointestinal pain—Methotrexate—psoriasis	7.93e-05	0.00029	CcSEcCtD
Trazodone—Nausea—Betamethasone—psoriasis	7.91e-05	0.000289	CcSEcCtD
Trazodone—Nausea—Dexamethasone—psoriasis	7.91e-05	0.000289	CcSEcCtD
Trazodone—Urticaria—Methotrexate—psoriasis	7.7e-05	0.000282	CcSEcCtD
Trazodone—Dizziness—Prednisone—psoriasis	7.67e-05	0.000281	CcSEcCtD
Trazodone—Abdominal pain—Methotrexate—psoriasis	7.66e-05	0.00028	CcSEcCtD
Trazodone—Body temperature increased—Methotrexate—psoriasis	7.66e-05	0.00028	CcSEcCtD
Trazodone—Vomiting—Prednisone—psoriasis	7.37e-05	0.00027	CcSEcCtD
Trazodone—Rash—Prednisone—psoriasis	7.31e-05	0.000268	CcSEcCtD
Trazodone—Dermatitis—Prednisone—psoriasis	7.31e-05	0.000267	CcSEcCtD
Trazodone—Headache—Prednisone—psoriasis	7.27e-05	0.000266	CcSEcCtD
Trazodone—Hypersensitivity—Methotrexate—psoriasis	7.14e-05	0.000261	CcSEcCtD
Trazodone—Asthenia—Methotrexate—psoriasis	6.95e-05	0.000254	CcSEcCtD
Trazodone—Nausea—Prednisone—psoriasis	6.89e-05	0.000252	CcSEcCtD
Trazodone—Pruritus—Methotrexate—psoriasis	6.86e-05	0.000251	CcSEcCtD
Trazodone—Diarrhoea—Methotrexate—psoriasis	6.63e-05	0.000243	CcSEcCtD
Trazodone—Dizziness—Methotrexate—psoriasis	6.41e-05	0.000235	CcSEcCtD
Trazodone—Vomiting—Methotrexate—psoriasis	6.16e-05	0.000226	CcSEcCtD
Trazodone—Rash—Methotrexate—psoriasis	6.11e-05	0.000224	CcSEcCtD
Trazodone—Dermatitis—Methotrexate—psoriasis	6.11e-05	0.000223	CcSEcCtD
Trazodone—Headache—Methotrexate—psoriasis	6.07e-05	0.000222	CcSEcCtD
Trazodone—Nausea—Methotrexate—psoriasis	5.76e-05	0.000211	CcSEcCtD
Trazodone—ADRA2A—GPCR ligand binding—CCL20—psoriasis	3.3e-05	0.00202	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—HCAR2—psoriasis	3.27e-05	0.00199	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—NDUFA5—psoriasis	3.11e-05	0.0019	CbGpPWpGaD
Trazodone—SLC6A4—SIDS Susceptibility Pathways—VEGFA—psoriasis	3.03e-05	0.00185	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—HCAR2—psoriasis	3.03e-05	0.00185	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—CCL20—psoriasis	2.93e-05	0.00179	CbGpPWpGaD
Trazodone—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	2.85e-05	0.00174	CbGpPWpGaD
Trazodone—SLC6A4—Circadian rythm related genes—JUN—psoriasis	2.84e-05	0.00173	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—ITGAL—psoriasis	2.73e-05	0.00166	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—CCL20—psoriasis	2.66e-05	0.00162	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—CYP2S1—psoriasis	2.64e-05	0.00161	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TAGAP—psoriasis	2.62e-05	0.0016	CbGpPWpGaD
Trazodone—ABCB1—Allograft Rejection—IFNG—psoriasis	2.62e-05	0.0016	CbGpPWpGaD
Trazodone—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	2.62e-05	0.0016	CbGpPWpGaD
Trazodone—HTR1A—SIDS Susceptibility Pathways—CXCL8—psoriasis	2.6e-05	0.00159	CbGpPWpGaD
Trazodone—SLC6A4—SIDS Susceptibility Pathways—TNF—psoriasis	2.6e-05	0.00159	CbGpPWpGaD
Trazodone—ADRA1A—AMPK Signaling—TP53—psoriasis	2.59e-05	0.00158	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—HCAR2—psoriasis	2.45e-05	0.0015	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—NDUFA5—psoriasis	2.45e-05	0.0015	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—HCAR2—psoriasis	2.44e-05	0.00149	CbGpPWpGaD
Trazodone—ABCB1—Allograft Rejection—CXCL8—psoriasis	2.44e-05	0.00149	CbGpPWpGaD
Trazodone—HTR1A—SIDS Susceptibility Pathways—JUN—psoriasis	2.42e-05	0.00148	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—CCL20—psoriasis	2.38e-05	0.00145	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—CCL20—psoriasis	2.36e-05	0.00144	CbGpPWpGaD
Trazodone—HTR1A—SIDS Susceptibility Pathways—NFKB1—psoriasis	2.33e-05	0.00142	CbGpPWpGaD
Trazodone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	2.3e-05	0.0014	CbGpPWpGaD
Trazodone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	2.29e-05	0.00139	CbGpPWpGaD
Trazodone—HTR2A—SIDS Susceptibility Pathways—CXCL8—psoriasis	2.25e-05	0.00137	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—NDUFA5—psoriasis	2.25e-05	0.00137	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—CCL20—psoriasis	2.16e-05	0.00132	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—CCL20—psoriasis	2.15e-05	0.00131	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TAGAP—psoriasis	2.13e-05	0.0013	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—HCAR2—psoriasis	2.12e-05	0.00129	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TAGAP—psoriasis	2.12e-05	0.00129	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—HCAR2—psoriasis	2.12e-05	0.00129	CbGpPWpGaD
Trazodone—HTR1A—SIDS Susceptibility Pathways—VEGFA—psoriasis	2.11e-05	0.00129	CbGpPWpGaD
Trazodone—SLC6A4—SIDS Susceptibility Pathways—IL6—psoriasis	2.1e-05	0.00128	CbGpPWpGaD
Trazodone—HTR2A—SIDS Susceptibility Pathways—JUN—psoriasis	2.09e-05	0.00128	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—CYP2S1—psoriasis	2.09e-05	0.00127	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—HCAR2—psoriasis	2.08e-05	0.00127	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—CCL20—psoriasis	2.05e-05	0.00125	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—CCL20—psoriasis	2.05e-05	0.00125	CbGpPWpGaD
Trazodone—HTR2A—SIDS Susceptibility Pathways—NFKB1—psoriasis	2.01e-05	0.00123	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—CCL20—psoriasis	2.01e-05	0.00123	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.01e-05	0.00122	CbGpPWpGaD
Trazodone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	2e-05	0.00122	CbGpPWpGaD
Trazodone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	1.99e-05	0.00122	CbGpPWpGaD
Trazodone—ABCB1—Allograft Rejection—VEGFA—psoriasis	1.98e-05	0.00121	CbGpPWpGaD
Trazodone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	1.96e-05	0.00119	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—HCAR2—psoriasis	1.93e-05	0.00118	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—CYP2S1—psoriasis	1.91e-05	0.00117	CbGpPWpGaD
Trazodone—HTR1A—G alpha (i) signalling events—CXCL8—psoriasis	1.88e-05	0.00114	CbGpPWpGaD
Trazodone—SLC6A4—Circadian rythm related genes—TP53—psoriasis	1.87e-05	0.00114	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—CCL20—psoriasis	1.87e-05	0.00114	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—CCL20—psoriasis	1.86e-05	0.00114	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—CCL20—psoriasis	1.86e-05	0.00113	CbGpPWpGaD
Trazodone—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.84e-05	0.00112	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TAGAP—psoriasis	1.84e-05	0.00112	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TAGAP—psoriasis	1.83e-05	0.00112	CbGpPWpGaD
Trazodone—HTR2A—SIDS Susceptibility Pathways—VEGFA—psoriasis	1.83e-05	0.00111	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—CCL20—psoriasis	1.83e-05	0.00111	CbGpPWpGaD
Trazodone—HTR1A—SIDS Susceptibility Pathways—TNF—psoriasis	1.81e-05	0.00111	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TAGAP—psoriasis	1.8e-05	0.0011	CbGpPWpGaD
Trazodone—SLC6A4—Circadian rythm related genes—IL6—psoriasis	1.71e-05	0.00105	CbGpPWpGaD
Trazodone—ABCB1—Allograft Rejection—TNF—psoriasis	1.7e-05	0.00104	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—NDUFA5—psoriasis	1.7e-05	0.00103	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—CCL20—psoriasis	1.7e-05	0.00103	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.69e-05	0.00103	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TAGAP—psoriasis	1.67e-05	0.00102	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—NDUFA5—psoriasis	1.6e-05	0.000975	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	1.58e-05	0.000962	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CCL20—psoriasis	1.57e-05	0.000959	CbGpPWpGaD
Trazodone—HTR2A—SIDS Susceptibility Pathways—TNF—psoriasis	1.57e-05	0.000955	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	1.5e-05	0.000917	CbGpPWpGaD
Trazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.49e-05	0.00091	CbGpPWpGaD
Trazodone—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.48e-05	0.000905	CbGpPWpGaD
Trazodone—ADRA2A—G alpha (i) signalling events—CXCL8—psoriasis	1.47e-05	0.000899	CbGpPWpGaD
Trazodone—HTR1A—SIDS Susceptibility Pathways—IL6—psoriasis	1.46e-05	0.000892	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CYP2S1—psoriasis	1.44e-05	0.00088	CbGpPWpGaD
Trazodone—HTR2B—GPCR ligand binding—CXCL8—psoriasis	1.4e-05	0.000854	CbGpPWpGaD
Trazodone—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	1.39e-05	0.000851	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CYP2S1—psoriasis	1.36e-05	0.000829	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—CARM1—psoriasis	1.29e-05	0.000788	CbGpPWpGaD
Trazodone—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.29e-05	0.000786	CbGpPWpGaD
Trazodone—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.29e-05	0.000784	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CCL20—psoriasis	1.27e-05	0.000778	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CCL20—psoriasis	1.27e-05	0.000774	CbGpPWpGaD
Trazodone—HTR2A—SIDS Susceptibility Pathways—IL6—psoriasis	1.26e-05	0.00077	CbGpPWpGaD
Trazodone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.26e-05	0.000769	CbGpPWpGaD
Trazodone—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.26e-05	0.000767	CbGpPWpGaD
Trazodone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.17e-05	0.000715	CbGpPWpGaD
Trazodone—HTR1A—GPCR ligand binding—CXCL8—psoriasis	1.14e-05	0.000693	CbGpPWpGaD
Trazodone—HTR2C—GPCR ligand binding—CXCL8—psoriasis	1.13e-05	0.000689	CbGpPWpGaD
Trazodone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	1.13e-05	0.000686	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—NOS2—psoriasis	1.12e-05	0.000683	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.12e-05	0.000682	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CCL20—psoriasis	1.1e-05	0.000672	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CCL20—psoriasis	1.1e-05	0.00067	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CCL20—psoriasis	1.08e-05	0.000658	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.08e-05	0.000657	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—NDUFA5—psoriasis	1.05e-05	0.000638	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—CARM1—psoriasis	1.02e-05	0.000621	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCL20—psoriasis	1e-05	0.000611	CbGpPWpGaD
Trazodone—HTR2A—GPCR ligand binding—CXCL8—psoriasis	9.81e-06	0.000598	CbGpPWpGaD
Trazodone—HRH1—GPCR ligand binding—CXCL8—psoriasis	9.79e-06	0.000597	CbGpPWpGaD
Trazodone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	9.77e-06	0.000596	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	9.77e-06	0.000596	CbGpPWpGaD
Trazodone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	9.75e-06	0.000595	CbGpPWpGaD
Trazodone—ADRA1A—GPCR ligand binding—CXCL8—psoriasis	9.61e-06	0.000586	CbGpPWpGaD
Trazodone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	9.57e-06	0.000584	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—CARM1—psoriasis	9.34e-06	0.000569	CbGpPWpGaD
Trazodone—ADRA2A—GPCR ligand binding—CXCL8—psoriasis	8.92e-06	0.000544	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP2S1—psoriasis	8.89e-06	0.000542	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—SOCS1—psoriasis	8.66e-06	0.000528	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	8.37e-06	0.000511	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—TYK2—psoriasis	8.25e-06	0.000503	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—CAT—psoriasis	7.94e-06	0.000485	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—CXCL8—psoriasis	7.91e-06	0.000483	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	7.38e-06	0.00045	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—CXCL8—psoriasis	7.19e-06	0.000438	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CARM1—psoriasis	7.04e-06	0.00043	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—SOCS1—psoriasis	7.02e-06	0.000428	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—SOCS1—psoriasis	6.98e-06	0.000426	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—TYK2—psoriasis	6.69e-06	0.000408	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—TYK2—psoriasis	6.66e-06	0.000406	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CARM1—psoriasis	6.64e-06	0.000405	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—VEGFA—psoriasis	6.48e-06	0.000395	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—CXCL8—psoriasis	6.42e-06	0.000391	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—APOE—psoriasis	6.39e-06	0.00039	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—LEP—psoriasis	6.39e-06	0.00039	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—CXCL8—psoriasis	6.38e-06	0.000389	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—CAT—psoriasis	6.27e-06	0.000382	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—APOE—psoriasis	6.17e-06	0.000377	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—SOCS1—psoriasis	6.06e-06	0.00037	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—SOCS1—psoriasis	6.05e-06	0.000369	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—NFKBIA—psoriasis	5.95e-06	0.000363	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—SOCS1—psoriasis	5.94e-06	0.000362	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—CXCL8—psoriasis	5.83e-06	0.000355	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—CXCL8—psoriasis	5.8e-06	0.000354	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—TYK2—psoriasis	5.78e-06	0.000353	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—TYK2—psoriasis	5.77e-06	0.000352	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—CAT—psoriasis	5.74e-06	0.00035	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—TYK2—psoriasis	5.66e-06	0.000345	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—CXCL8—psoriasis	5.54e-06	0.000338	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—CXCL8—psoriasis	5.53e-06	0.000337	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SOCS1—psoriasis	5.52e-06	0.000337	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—CXCL8—psoriasis	5.43e-06	0.000331	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—PPARG—psoriasis	5.38e-06	0.000328	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—TYK2—psoriasis	5.26e-06	0.000321	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—LEP—psoriasis	5.18e-06	0.000316	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—APOE—psoriasis	5.18e-06	0.000316	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—APOE—psoriasis	5.15e-06	0.000314	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—LEP—psoriasis	5.15e-06	0.000314	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—CXCL8—psoriasis	5.04e-06	0.000308	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—CXCL8—psoriasis	5.03e-06	0.000307	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—CXCL8—psoriasis	5.02e-06	0.000306	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—CXCL8—psoriasis	4.93e-06	0.000301	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—TP53—psoriasis	4.9e-06	0.000299	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TYK2—psoriasis	4.88e-06	0.000297	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—APOE—psoriasis	4.87e-06	0.000297	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—NFKBIA—psoriasis	4.83e-06	0.000294	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—NFKBIA—psoriasis	4.8e-06	0.000293	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—CXCL8—psoriasis	4.58e-06	0.000279	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—APOE—psoriasis	4.47e-06	0.000273	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—LEP—psoriasis	4.47e-06	0.000273	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—LEP—psoriasis	4.47e-06	0.000272	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—APOE—psoriasis	4.47e-06	0.000272	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—APOE—psoriasis	4.46e-06	0.000272	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—APOE—psoriasis	4.38e-06	0.000267	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—LEP—psoriasis	4.38e-06	0.000267	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CARM1—psoriasis	4.34e-06	0.000265	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CAT—psoriasis	4.33e-06	0.000264	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CXCL8—psoriasis	4.24e-06	0.000259	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PPARG—psoriasis	4.24e-06	0.000259	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—NFKBIA—psoriasis	4.17e-06	0.000254	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—NFKBIA—psoriasis	4.16e-06	0.000254	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CAT—psoriasis	4.08e-06	0.000249	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—NFKBIA—psoriasis	4.08e-06	0.000249	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—LEP—psoriasis	4.07e-06	0.000248	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—APOE—psoriasis	4.07e-06	0.000248	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—IL6—psoriasis	4.04e-06	0.000246	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TYK2—psoriasis	3.95e-06	0.000241	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—JUN—psoriasis	3.95e-06	0.000241	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TYK2—psoriasis	3.93e-06	0.00024	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PPARG—psoriasis	3.89e-06	0.000237	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—NFKB1—psoriasis	3.8e-06	0.000232	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—NFKBIA—psoriasis	3.79e-06	0.000231	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—VEGFA—psoriasis	3.45e-06	0.00021	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CXCL8—psoriasis	3.44e-06	0.00021	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CXCL8—psoriasis	3.42e-06	0.000209	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TYK2—psoriasis	3.42e-06	0.000208	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—STAT3—psoriasis	3.41e-06	0.000208	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TYK2—psoriasis	3.41e-06	0.000208	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—APOE—psoriasis	3.37e-06	0.000205	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TYK2—psoriasis	3.34e-06	0.000204	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—IL6—psoriasis	3.27e-06	0.0002	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—IL6—psoriasis	3.26e-06	0.000199	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—JUN—psoriasis	3.2e-06	0.000195	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—JUN—psoriasis	3.18e-06	0.000194	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—APOE—psoriasis	3.17e-06	0.000194	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TYK2—psoriasis	3.11e-06	0.00019	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—NFKB1—psoriasis	3.08e-06	0.000188	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—NFKB1—psoriasis	3.06e-06	0.000187	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CXCL8—psoriasis	2.97e-06	0.000181	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CXCL8—psoriasis	2.97e-06	0.000181	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PPARG—psoriasis	2.93e-06	0.000179	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CXCL8—psoriasis	2.91e-06	0.000178	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—IL6—psoriasis	2.83e-06	0.000172	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—IL6—psoriasis	2.82e-06	0.000172	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—VEGFA—psoriasis	2.8e-06	0.000171	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—VEGFA—psoriasis	2.78e-06	0.00017	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—IL6—psoriasis	2.77e-06	0.000169	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—STAT3—psoriasis	2.77e-06	0.000169	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—JUN—psoriasis	2.76e-06	0.000169	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PPARG—psoriasis	2.76e-06	0.000169	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—JUN—psoriasis	2.76e-06	0.000168	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—STAT3—psoriasis	2.75e-06	0.000168	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—JUN—psoriasis	2.71e-06	0.000165	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CXCL8—psoriasis	2.71e-06	0.000165	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CAT—psoriasis	2.67e-06	0.000163	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—NFKB1—psoriasis	2.66e-06	0.000162	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—NFKB1—psoriasis	2.66e-06	0.000162	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—NFKB1—psoriasis	2.61e-06	0.000159	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TP53—psoriasis	2.6e-06	0.000159	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—IL6—psoriasis	2.57e-06	0.000157	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—JUN—psoriasis	2.52e-06	0.000153	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—NFKB1—psoriasis	2.42e-06	0.000148	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—VEGFA—psoriasis	2.42e-06	0.000147	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—VEGFA—psoriasis	2.41e-06	0.000147	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—STAT3—psoriasis	2.39e-06	0.000146	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—STAT3—psoriasis	2.39e-06	0.000146	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IL6—psoriasis	2.38e-06	0.000145	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—VEGFA—psoriasis	2.36e-06	0.000144	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—STAT3—psoriasis	2.34e-06	0.000143	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—VEGFA—psoriasis	2.2e-06	0.000134	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—STAT3—psoriasis	2.18e-06	0.000133	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TP53—psoriasis	2.11e-06	0.000129	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TP53—psoriasis	2.1e-06	0.000128	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—APOE—psoriasis	2.07e-06	0.000127	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL6—psoriasis	1.93e-06	0.000118	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL6—psoriasis	1.92e-06	0.000117	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TP53—psoriasis	1.82e-06	0.000111	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TP53—psoriasis	1.82e-06	0.000111	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PPARG—psoriasis	1.81e-06	0.00011	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TP53—psoriasis	1.79e-06	0.000109	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL6—psoriasis	1.67e-06	0.000102	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL6—psoriasis	1.67e-06	0.000102	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TP53—psoriasis	1.66e-06	0.000101	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL6—psoriasis	1.64e-06	9.98e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL6—psoriasis	1.52e-06	9.27e-05	CbGpPWpGaD
